Heart Rate response and cardiovascular risk during OSA: an easy biomarker derived from pulse oximetry.

IF 16.6 1区 医学 Q1 RESPIRATORY SYSTEM European Respiratory Journal Pub Date : 2025-02-20 DOI:10.1183/13993003.01883-2024
Margaux Blanchard, Théo Imler, Wen-Hsin Hu, Adrien Waeber, Geoffroy Solelhac, José Haba-Rubio, Sandrine Kerbrat, Abdelkebir Sabil, Wojciech Trzepizur, François Goupil, Audrey Thomas, Sébastien Bailly, Ali Azarbarzin, Peter Vollenweider, Pedro Marques-Vidal, Julien Vaucher, Raphael Heinzer, Frédéric Gagnadoux
{"title":"Heart Rate response and cardiovascular risk during OSA: an easy biomarker derived from pulse oximetry.","authors":"Margaux Blanchard, Théo Imler, Wen-Hsin Hu, Adrien Waeber, Geoffroy Solelhac, José Haba-Rubio, Sandrine Kerbrat, Abdelkebir Sabil, Wojciech Trzepizur, François Goupil, Audrey Thomas, Sébastien Bailly, Ali Azarbarzin, Peter Vollenweider, Pedro Marques-Vidal, Julien Vaucher, Raphael Heinzer, Frédéric Gagnadoux","doi":"10.1183/13993003.01883-2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sleep apnoea specific heart rate response (ΔHR) has been identified as a promising biomarker for stratifying cardiovascular (CV) risk, and predicting positive airway pressure (PAP) benefit in obstructive sleep apnoea (OSA). However, the need for prior manual scoring of respiratory events potentially limits the accessibility and reproducibility of ΔHR. We aimed to evaluate the association of pulse rate response to oxygen desaturations automatically derived from pulse oximetry (ΔHR<sub>oxi</sub>) with CV risk in OSA.</p><p><strong>Methods: </strong>ΔHR<sub>oxi</sub> and ΔHR were measured in OSA patients from the <i>IRSR Pays de la Loire Sleep Cohort</i> (<i>PLSC;</i> n=5,002) and the <i>HypnoLaus</i> cohort (n=1,307). The primary outcome was major adverse CV events (MACEs), a composite of mortality, stroke, and cardiac diseases. Cox regressions analyses were conducted to evaluate the association of ΔHR<sub>oxi</sub> and ΔHR categorized into low, midrange and high categories, with MACEs.</p><p><strong>Results: </strong>MACEs occured in 768 patients from <i>PLSC</i> and 87 patients from <i>HypnoLaus</i> (median follow-up: 8.0 and 7.5 years respectively). Multivariable Cox models showed that subjects with high ΔHR<sub>oxi</sub> (vs midrange) had higher risk of MACEs in <i>PLSC</i> (hazard ratio, HR: 1.42 [95% CI:1.18-1.71]) and <i>HypnoLaus</i> (HR: 1.72 [1.03-2.87]). Similar findings were observed for high ΔHR. Among 2,718 patients from <i>PLSC</i> treated with PAP, the association of PAP adherence (PAP use ≥4 h/night, vs non adherence) with MACEs was modified by baseline ΔHR and ΔHR<sub>oxi</sub> (p for interaction<0.05).</p><p><strong>Conclusions: </strong>ΔHR<sub>oxi</sub> could constitute a reliable and easy to measure biomarker for stratifying CV risk and predicting CV benefit of PAP in OSA.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.01883-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sleep apnoea specific heart rate response (ΔHR) has been identified as a promising biomarker for stratifying cardiovascular (CV) risk, and predicting positive airway pressure (PAP) benefit in obstructive sleep apnoea (OSA). However, the need for prior manual scoring of respiratory events potentially limits the accessibility and reproducibility of ΔHR. We aimed to evaluate the association of pulse rate response to oxygen desaturations automatically derived from pulse oximetry (ΔHRoxi) with CV risk in OSA.

Methods: ΔHRoxi and ΔHR were measured in OSA patients from the IRSR Pays de la Loire Sleep Cohort (PLSC; n=5,002) and the HypnoLaus cohort (n=1,307). The primary outcome was major adverse CV events (MACEs), a composite of mortality, stroke, and cardiac diseases. Cox regressions analyses were conducted to evaluate the association of ΔHRoxi and ΔHR categorized into low, midrange and high categories, with MACEs.

Results: MACEs occured in 768 patients from PLSC and 87 patients from HypnoLaus (median follow-up: 8.0 and 7.5 years respectively). Multivariable Cox models showed that subjects with high ΔHRoxi (vs midrange) had higher risk of MACEs in PLSC (hazard ratio, HR: 1.42 [95% CI:1.18-1.71]) and HypnoLaus (HR: 1.72 [1.03-2.87]). Similar findings were observed for high ΔHR. Among 2,718 patients from PLSC treated with PAP, the association of PAP adherence (PAP use ≥4 h/night, vs non adherence) with MACEs was modified by baseline ΔHR and ΔHRoxi (p for interaction<0.05).

Conclusions: ΔHRoxi could constitute a reliable and easy to measure biomarker for stratifying CV risk and predicting CV benefit of PAP in OSA.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
背景:睡眠呼吸暂停特异性心率反应(ΔHR)已被确定为一种很有前景的生物标志物,可用于对阻塞性睡眠呼吸暂停(OSA)患者进行心血管(CV)风险分层并预测气道正压(PAP)的益处。然而,由于需要事先对呼吸事件进行人工评分,ΔHR 的可及性和可重复性受到了潜在的限制。我们的目的是评估脉搏血氧仪(ΔHRoxi)自动得出的氧不饱和脉率反应与 OSA 中 CV 风险的关系。方法:对 IRSR 卢瓦尔河地区睡眠队列(PLSC;n=5002)和 HypnoLaus 队列(n=1307)中的 OSA 患者进行ΔHRoxi 和 ΔHR 测量。主要研究结果是主要心血管不良事件(MACEs),即死亡率、中风和心脏病的综合指数。对ΔHRoxi和分为低、中、高三类的ΔHR与MACEs的关系进行了Cox回归分析:768名PLSC患者和87名HypnoLaus患者发生了MACE(中位随访时间分别为8.0年和7.5年)。多变量 Cox 模型显示,在 PLSC(危险比 HR:1.42 [95% CI:1.18-1.71])和 HypnoLaus(HR:1.72 [1.03-2.87])中,ΔHRoxi 较高(与中值相比)的受试者发生 MACE 的风险较高。高ΔHR也有类似结果。在接受PAP治疗的2718名PLSC患者中,PAP依从性(PAP使用时间≥4小时/晚,与非依从性相比)与MACEs的关系受基线ΔHR和ΔHRoxi的影响(p为交互作用结论:ΔHRoxi可作为一种可靠且易于测量的生物标志物,用于对OSA患者的CV风险进行分层并预测PAP对CV的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Respiratory Journal
European Respiratory Journal 医学-呼吸系统
CiteScore
27.50
自引率
3.30%
发文量
345
审稿时长
2-4 weeks
期刊介绍: The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.
期刊最新文献
Prenatal exposure to greenness and early childhood pneumonia: A nationwide study in Japan. Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): A randomised controlled trial of exercise-based rehabilitation. Proposal for a rational and sustainable use of antimicrobial filters in pulmonary function testing. Transcriptomic profiling of the airway epithelium in COPD links airway eosinophilia to type 2 inflammation and corticosteroid response. A Long-Term Follow-Up Study of Sotatercept for Treatment of Pulmonary Arterial Hypertension: Interim Results of SOTERIA.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1